Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates
2002 ◽
Vol 46
(3)
◽
pp. 909-912
◽
Keyword(s):
ABSTRACT The phenomenon of cross-resistance to antiretroviral agents used to treat human immunodeficiency virus type 1 infection is well known but so far has been only qualitatively described. Here, we quantitate the degree of cross-resistance among all commonly prescribed antiretroviral agents in almost 5,000 clinically derived recombinant isolates collected in the United States since January 2000.
2000 ◽
Vol 74
(9)
◽
pp. 4414-4419
◽
1996 ◽
Vol 36
(5)
◽
pp. 398-400
◽
1992 ◽
Vol 30
(1)
◽
pp. 126-131
◽
2001 ◽
Vol 184
(9)
◽
pp. 1120-1126
◽
2006 ◽
Vol 25
(11)
◽
pp. 987-994
◽
1995 ◽
Vol 33
(2)
◽
pp. 481-483
◽
2002 ◽
Vol 18
(6)
◽
pp. 413-417
◽